ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

Propac To Recommend Reclassification Of Five Leukemia/Lymphoma Diagnosis Related Groups

March 21, 1986

DOD Breast Cancer Program Releases Research Solicitation

October 1, 1993

Funding Opportunities: DOD releases PA On Ovarian Cancer

August 6, 1999

O’Conor Names DCCP Director, Says He’ll Push Development Of NCI’s Efforts In Epidemiology

April 28, 1978

NCI CTEP Approved Trials For the Month of November

November 29, 2013

House Launches Probe of NCI Spending On Cancer Communications, Education

April 12, 2013